This paper discusses the scale-up feasibility and industrial adoption of polyhydroxyalkanoates (PHAs), emphasizing the need to link PHA development with recycling technologies and highlighting strategies for designing PHAs for closed-loop recycling.
No takes yet. Share an insight, caveat, or question.
Clarke et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: